glp 1 agonist in pregnancy Prenatal exposure to GLP-1 receptor agonists and other second-line antidiabetics may not pose greater risk to infants than insulin Preconception GLP-1 receptor agonist use
Description
Work with your clinician to optimize the dose ramp, slow the weekly loss rate if feasible , and screen for correctable deficiencies
Request customization and get the insights tailored to your exact requirements
Weight reduction Compared with placebo, use of dulaglutide 1.5 mg once weekly led to a 1.5 kg (95% CI 1.3 to 1.7 kg) weight reduction over five years
Christensen, M., Miossec, P., Larsen, B
Figure 31: Photograph of Professor Bernard Thorens, credit Center for Integrative Genomics, University of Lausanne
